share_log

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

考慮到每股收益增長等因素,Stryker(紐交所:SYK)成爲一個有趣的案例。
Simply Wall St ·  06/16 21:56

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad.

許多投資者,特別是沒經驗的投資者,買入公司的股份時會想要聽取一個好故事,即使那些公司虧損。不幸的是,這些高風險投資往往幾乎沒有實現其付出的可能性,許多投資者會爲此付出代價去吸取教訓。虧損公司會像一塊資金的海綿,因此投資者要謹慎,以免把好錢投進去壞錢後面。

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Stryker (NYSE:SYK). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing.

如果高風險和高回報的理念不適合您,您可能更感興趣的是像Stryker(NYSE:SYK)這樣盈利增長的公司。雖然這不一定表明它被低估了,但業務的盈利足以支持一些讚賞,尤其是如果它在不斷增長。

How Fast Is Stryker Growing?

Stryker的增長速度有多快?

Generally, companies experiencing growth in earnings per share (EPS) should see similar trends in share price. That makes EPS growth an attractive quality for any company. It certainly is nice to see that Stryker has managed to grow EPS by 33% per year over three years. If growth like this continues on into the future, then shareholders will have plenty to smile about.

一般來說,每股收益(EPS)增長的公司應該看到類似的股價趨勢。這使得EPS的增長成爲任何公司的有吸引力的品質。很高興看到Stryker在過去三年中每年的每股收益增長了33%。如果這樣的增長持續到未來,股東們將擁有足夠的理由微笑。

Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. The music to the ears of Stryker shareholders is that EBIT margins have grown from 19% to 21% in the last 12 months and revenues are on an upwards trend as well. That's great to see, on both counts.

仔細考慮營業收入增長和利息和所得稅前利潤率(EBIT)可以幫助了解近期利潤增長的可持續性。Stryker股東們所想要聽到的是,EBIT利潤率在最近12個月內從19%增長到21%,營業收入也呈上升趨勢。兩個因素都表現得很好。

You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart.

您可以查看下面的圖表,了解公司的營收和利潤增長趨勢。要查看實際數字,請單擊圖表。

earnings-and-revenue-history
NYSE:SYK Earnings and Revenue History June 16th 2024
NYSE:SYK收益和營業收入歷史。2024年6月16日

While we live in the present moment, there's little doubt that the future matters most in the investment decision process. So why not check this interactive chart depicting future EPS estimates, for Stryker?

雖然我們生活在當下,但毫無疑問,未來最爲重要。那麼,爲什麼不查看展現Stryker未來EPS預測的交互式圖表呢?

Are Stryker Insiders Aligned With All Shareholders?

Stryker內部人士是否與所有股東保持一致?由於Stryker的規模,我們不期望內部人士持有公司的大部分股份。但事實證明,他們已經投資了該公司的可觀財富,目前價值130億美元。這表明,在做出決策時,領導層會非常注意股東的利益!

Owing to the size of Stryker, we wouldn't expect insiders to hold a significant proportion of the company. But we are reassured by the fact they have invested in the company. Indeed, they have a considerable amount of wealth invested in it, currently valued at US$13b. This suggests that leadership will be very mindful of shareholders' interests when making decisions!

Stryker值得關注嗎?對於成長型投資者,Stryker的原始盈利增長率是夜間的燈塔。這種EPS增長率是公司應該感到自豪的,因此不足爲奇的是內部人士持有大量股份。快速增長和有信心的內部人士應該足以促使進一步研究,因此它似乎是一個不錯的股票。但值得注意的是,我們發現了2個有關Stryker的警告信號,需要考慮。

Is Stryker Worth Keeping An Eye On?

雖然Stryker看起來非常不錯,但如果內部人士購買了更多股份,可能更受到投資者的青睞。如果您想查看更多擁有內部人士支持的公司,它們不僅擁有強勁的增長,而且擁有內部人士的堅定支持,請查看此精選的公司選項。

For growth investors, Stryker's raw rate of earnings growth is a beacon in the night. This EPS growth rate is something the company should be proud of, and so it's no surprise that insiders are holding on to a considerable chunk of shares. Fast growth and confident insiders should be enough to warrant further research, so it would seem that it's a good stock to follow. It is worth noting though that we have found 2 warning signs for Stryker that you need to take into consideration.

如果高風險和高回報的理念不適合您,您可能更感興趣的是像Stryker(NYSE:SYK)這樣盈利增長的公司。雖然這不一定表明它被低估了,但業務的盈利足以支持一些讚賞,尤其是如果它在不斷增長。一般來說,每股收益(EPS)增長的公司應該看到類似的股價趨勢。這使得EPS的增長成爲任何公司的有吸引力的品質。很高興看到Stryker在過去三年中每年的每股收益增長了33%。如果這樣的增長持續到未來,股東們將擁有足夠的理由微笑。仔細考慮營業收入增長和利息和所得稅前利潤率(EBIT)可以幫助了解近期利潤增長的可持續性。Stryker股東們所想要聽到的是,EBIT利潤率在最近12個月內從19%增長到21%,營業收入也呈上升趨勢。兩個因素都表現得很好。雖然我們生活在當下,但毫無疑問,未來最爲重要。那麼,爲什麼不查看展現Stryker未來EPS預測的交互式圖表呢?Stryker內部人士是否與所有股東保持一致?由於Stryker的規模,我們不期望內部人士持有公司的大部分股份。但事實證明,他們已經投資了該公司的可觀財富,目前價值130億美元。這表明,在做出決策時,領導層會非常注意股東的利益!對於成長型投資者,Stryker的原始盈利增長率是夜間的燈塔。這種EPS增長率是公司應該感到自豪的,因此不足爲奇的是內部人士持有大量股份。快速增長和有信心的內部人士應該足以促使進一步研究,因此它似乎是一個不錯的股票。但值得注意的是,我們發現了2個有關Stryker的警告信號,需要考慮。雖然Stryker看起來非常不錯,但如果內部人士購買了更多股份,可能更受到投資者的青睞。如果您想查看更多擁有內部人士支持的公司,它們不僅擁有強勁的增長,而且擁有內部人士的堅定支持,請查看此精選的公司選項。

Although Stryker certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of companies that not only boast of strong growth but have strong insider backing.

雖然Stryker看起來非常不錯,但如果內部人士購買了更多股份,可能更受到投資者的青睞。如果您想查看更多擁有內部人士支持的公司,它們不僅擁有強勁的增長,而且擁有內部人士的堅定支持,請查看此精選的公司選項。

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

請注意,本文討論的內部交易是指在相關司法管轄區中報告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論